Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis

Journal of Physiology and Pharmacology

Volumn 60, Issue 2, 2009, Pages 29-34

  Ahluwalia, A ^b   Li, A ^b   Cheng, G ^b   Deng, X ^b   Tarnawski, Andrzej S ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Aging; Angiogenesis; Ghrelin; Human microvascular endothelial cells

Indexed keywords

GHRELIN; MITOGEN ACTIVATED PROTEIN KINASE;

AGE DISTRIBUTION; AGED; AGING; ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; AGING; CAPILLARIES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GHRELIN; HUMANS; INFANT, NEWBORN; MAP KINASE SIGNALING SYSTEM; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; RECEPTORS, GHRELIN;

EID: 68049100162     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-release acylated peptide from stomach. Nature 1999; 402: 656-660. (Pubitemid 129516334)
2. Date Y, Kojima M, Hosoda H, Sawaguchi A et al. Ghrelin, a novel growth hormone releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and human. Endocrinology 2000; 141: 4255-4256. (Pubitemid 30953541)
3. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001; 12: 118-122. (Pubitemid 33714199)
4. Kotunia A, Zabielski R. Ghrelin in the postnatal development of the gastrointestinal tract. J Physiol Pharmacol 2006; 57 (Suppl 5): 97-111. (Pubitemid 46569787)
5. Nagaya N, Miyatake K, Uematsu M et al. Hemodynamic, renal and hormonal effects of ghrelin infusion in patients with chronic heart failure. Clin Endocrinol Metab 2001; 86: 5854-5859. (Pubitemid 33152634)
6. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002; 136: 1146-11142
7. Kleinz M J, Maguire JJ, Skepper JN, Davenport A P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 2006; 69: 227-235.
8. King MK, Gay DM, Pan LC et al. Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function. Circulation 2003; 103: 308-313.
9. Li WG, Gavrila D, Liu X et al. Ghrelin inhibits proinflammatory response and nuclear factor- B activation in human endothelial cells. Circulation 2004; 109: 2221-2226. (Pubitemid 38625400)
10. Tesauro M, Schinzari F, Iantorno M et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005; 112: 2986-2992. (Pubitemid 41612302)
11. Konturek PC, Brzozowski T, Walter B et al. Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. Eur J Pharmacol 2006; 536: 171-181.
12. Brzozowski T, Konturek PC, Sliwowski Z et al. Prostaglandin/ cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 2006; 319: 477-478. (Pubitemid 44455155)
13. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005; 50: S24-S33. (Pubitemid 41380795)
14. Li A, Cheng G, Zhu G, Tarnawski AS. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: Implications beyond GH release. BBRC 2007; 353: 238-243. (Pubitemid 46014561)
15. Malara B, Josko J, Tyrpien M, Malara P, Steplewska K. Dynamics of changes in vascular endothelial growth factor (VEGF) expression and angiogenesis in stress-induced gastric ulceration in rats. J Physiol Pharmacol. 2005; 56: 259-271. (Pubitemid 40911092)
16. Tanigawa T, Pai R, Arakawa T, Higuchi K, Tarnawski AS. TGF-beta signaling pathway: its role in gastrointestinal pathophysiology and modulation of ulcer healing. J Physiol Pharmacol 2005; 56: 3-13 (Pubitemid 40477886)
17. Swift ME, Kleinman H, DiPetro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest 1999; 79: 1479-1487. (Pubitemid 30013913)
18. Wu L, Xia YP, Roth SI, Gruski E, Mustoe TA. Transforming growth factor-beta1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: importance of oxygen and age. Am J Pathol 1999; 154: 301-309. (Pubitemid 29031637)
19. Gosain A, DiPietro LA. Aging and wound healing. World J Surg 2004; 28: 321-326.
20. Edelberg JM, Reed MJ. Aging and angiogenesis. Front Biosci 2003; 8: s1199-s1209.
21. Rivard A, Fabre JE, Silver M et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120.
22. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Histochem Cytochem 2003; 51: 1119-1130. (Pubitemid 37059523)
23. Tarnawski A, Hollander, D, Stachura J, Gergely H, Krause WJ, Sarfeh IJ. Role of angiogenesis in healing of experimental gastric ulcer. In Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Dordrecht/Boston/ London, Kluwer Acad. Publ., 1991, pp.165-171.
24. Jones MK, Wang H, Peskar BM et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423.
25. Brzozowski T, Konturek PC, Sliwowski Z et al. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol 2006; 57 (Suppl 6): 63-76. (Pubitemid 46548802)
26. Warzecha Z, Dembinski A, Ceranowicz P et al. Influence of ghrelin on gastric and duodenal growth and expression of digestive enzymes in young mature rats. J Physiol Pharmacol. 2006; 57(3): 425-437. (Pubitemid 44543877)
27. Ariyasu H, Iwakura H, Yamada G, Nakao K, Kangawa K, Akamizu T. Efficacy of ghrelin as a therapeutic approach for age-related physiological changes. Endocrinology 2008; 149: 3722-3728. (Pubitemid 351919584)
28. Smith RG, Sun Y, Jiang H, Albarran-Zeckler R, Timchenko N. Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging. Ann N Y Acad Sci 2007; 1119: 147-164. (Pubitemid 350191240)
29. Kamei M, Saunders WB, Bayless KJ, Dye L, Davis GE, Weinstein BM. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006; 442: 453-456. (Pubitemid 44264794)
30. Chai J, Jones MK, Tarnawski AS. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis. FASEB J 2004; 18: 1264-1266. (Pubitemid 39561571)
31. Murata M, Okimura Y, Iida K et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002; 277: 5667-5674. (Pubitemid 34968622)